
PARP Inhibitor Drug is Granted Orphan Drug Designation for Pancreatic Cancer
According to a story from BioSpace, AstraZeneca and Merck released a joint announcement recently stating that the US Food and Drug Administration (FDA) has granted Orphan Drug designation to olaparib…